Search

Displaying results 4161 - 4170 of 5451 in total
  1. Drug

    Rebastinib

    go.drugbank.com/drugs/DB13005
    Investigational

    It is an inhibitor of Tie2 tyrosine kinase receptor and an antineoplastic agent.

  2. Drug

    XmAb24306

    go.drugbank.com/drugs/DB17526
    Investigational

    It is a heterodimeric interleukin (IL)-15/IL-15-receptor alpha (IL-15Ra) complex fused to a bispecific Fc domain.

  3. Drug

    Ozekibart

    go.drugbank.com/drugs/DB18675
    Investigational

    It is being investigated for the treatment of chondrosarcoma.

  4. Drug

    Theanine

    go.drugbank.com/drugs/DB12444
    Investigational

    It is under investigation in clinical trial NCT00291070 (Effects of L-Theanine in Boys With ADHD).

  5. Drug

    Lazucirnon

    go.drugbank.com/drugs/DB15269
    Investigational

    ALK-4290 is under investigation in clinical trial NCT03558061 (Evaluate the Effects and Safety of ALK4290 in Patients With Newly Diagnosed Wet Age-Related Macular Degeneration).

  6. Drug

    Chlorhexadol

    go.drugbank.com/drugs/DB01534
    IllicitInvestigational

    It is a derivative of chloral hydrate.

  7. Drug

    Diprenorphine

    go.drugbank.com/drugs/DB01548
    IllicitInvestigationalVet approved

    It is used to remobilize animals after etorphine neuroleptanalgesia and is considered a specific antagonist to etorphine. [PubChem]

  8. Drug

    Sphingosine

    go.drugbank.com/drugs/DB03203
    Investigational

    (Dorland, 28th ed)

  9. Drug

    Tosylchloramide

    go.drugbank.com/drugs/DB14708
    Investigational

    Tosylchloramide, also known as chloramine-T, is a chlorinated and deprotonated sulfonamide used as a mild disinfectant. It is not stable in the water dissolved form.

    Salts: Chloramine-T, Chloramine-T trihydrateInternational brands: Chloramin T
  10. Drug

    TAK-611

    go.drugbank.com/drugs/DB17644
    Investigational

    First developed by Takeda, it is being investigated for the treatment of metachromatic leukodystrophy.